$LLY

$Eli Lilly and Co(LLY.US)$ Today’s AdCom results for Donanemab… 🎉

⇨ Committee voted unanimously (11-0) 👍👍👍👍👍👍👍👍👍👍👍
» the available data show donanemab is effective for treating #Alzheimer's disease in patients with mild cognitive impairment and mild dementia

⇨ They also unanimously agreed (11-0) 👍👍👍👍👍👍👍👍👍👍👍
» the benefits outweigh the risks for this population

Will the FDA decision follow the results of this favorable AdCom meeting? 🤔